Recursion Pharmaceuticals, Inc. · NASDAQ:RXRX
Khan Najat had 85,815 Recursion Pharmaceuticals, Inc. shares withheld for tax (Form 4)
Traded Nov 16, 2026 · Filed Nov 18, 2026
On Nov 16, 2026, Khan Najat (Director, CEO and President) had 85,815 Recursion Pharmaceuticals, Inc. shares withheld for tax at US$3.19 for US$273K, leaving 1,987,075 shares. Filed Nov 18, 2026 (Form 4).
- Withheld for tax
- 85,815 shares
- Price
- US$3.19
- Value
- US$273K
- Holding after
- 1,987,075 shares
- Trading plan
- No
- Role
- Director, CEO and President
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 16, 2026 | Class A Common Stock | Shares withheld for tax | 85,815 | US$3.19 | 1,987,075 | Direct |
Source
Download original · View original at SEC
Related
- Recursion Pharmaceuticals, Inc.
- Khan Najat
- Recursion Pharmaceuticals, Inc. shareholders
- Form 4 · Khan Najat · Sep 10, 2026
- Form 4 · Khan Najat · Aug 18, 2026
- Form 4 · Khan Najat · Jun 5, 2026
- Form 4 · Khan Najat · May 19, 2026
- Form 4 · Taylor Ben R · Nov 18, 2026
- Form 4 · Hallett David · Nov 18, 2026
- Schedule 13G/A · ARK Investment Management LLC · Nov 13, 2026
- Schedule 13G · State Street Corp · Nov 10, 2026
- Form 4 · Borgeson Blake · Nov 4, 2026